FDA petitioned to ban Orlistat
April 12, 2006 on 4:08 pm | In Prescribing Extra - Drugs |
Print
|
Public Citizen have petitioned the Food and Drugs Administration in the United States to withdraw Orlistat (Xenical)® from the market amid claims it may be linked to colonic cancer.
In a press statement it is claimed that orlistat is associated with a significant increase in aberrant crypt foci, which are widely believed to be a precursor to colon cancer. This comes at a time when orlistat is being considered for availability to purchase “over the counter” in community pharmacy.
Action: Clinicians who prescribe orlistat should be aware of this development. Patients may ask questions if this information is reported in the media.
[Source: PharmaGossip]
Bookmark in del.icio.us